EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 382 filers reported holding EXELIXIS INC in Q1 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $515,000 | +442.1% | 32,870 | +682.1% | 0.02% | +500.0% |
Q1 2022 | $95,000 | +31.9% | 4,203 | +6.6% | 0.00% | +50.0% |
Q4 2021 | $72,000 | -82.0% | 3,941 | -77.8% | 0.00% | -85.7% |
Q1 2021 | $401,000 | +105.6% | 17,757 | +123.1% | 0.01% | -33.3% |
Q3 2020 | $195,000 | +242.1% | 7,959 | +140.6% | 0.02% | -16.0% |
Q1 2020 | $57,000 | -61.2% | 3,308 | -60.2% | 0.02% | -40.5% |
Q3 2019 | $147,000 | +182.7% | 8,302 | +244.3% | 0.04% | +200.0% |
Q2 2019 | $52,000 | +57.6% | 2,411 | +75.0% | 0.01% | +7.7% |
Q1 2019 | $33,000 | -10.8% | 1,378 | -16.4% | 0.01% | -31.6% |
Q1 2018 | $37,000 | +146.7% | 1,648 | +227.6% | 0.02% | +72.7% |
Q4 2017 | $15,000 | +66.7% | 503 | +43.3% | 0.01% | +83.3% |
Q3 2017 | $9,000 | -75.7% | 351 | -79.2% | 0.01% | -87.5% |
Q1 2017 | $37,000 | +208.3% | 1,687 | +116.3% | 0.05% | +300.0% |
Q4 2016 | $12,000 | – | 780 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |